Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Ilavarasu, Judu
- National-Level Coordination Strategies Needed to Mitigate the Outburst of Diabetes
Abstract Views :280 |
PDF Views:71
Authors
Affiliations
1 College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, TW
2 SVYASA University, Bengaluru 560 105, IN
1 College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, TW
2 SVYASA University, Bengaluru 560 105, IN
Source
Current Science, Vol 117, No 9 (2019), Pagination: 1430-1432Abstract
The burden of various diseases has been draining India’s economy in recent decades since the country harbours over 1.3 billion people. Diabetes is a lifestyle-related non-communicable disease, and it has become an epidemic in India affecting over 150 million people. The Government of India spends USD 10 billion per year to confront diabetes, but is unable to contain the outburst. This note analyses the existing facts on diabetes control measures adopted by the Government. It also provides future implementation strategies to be coordinated by various State and Central Government agencies in cooperation with private healthcare firms and non-government organizations to control the upsurge of diabetes in the near future.Full Text
References
- Kaveeshwar, S. A. and Cornwall, J., Austr. Med. J., 2014, 7(1), 45–48.
- India State-Level Disease Burden Initiative Diabetes Collaborators. Lancet Global Health, 11 September 2018, p. ii; S2214-109X(18)30387-5.
- Debnath, P., Banerjee, S., Adhikari, A., and Debnath, P. K., J. Evid. Based Complement. Altern. Med., 2017, 22(2), 294–298.
- Prathikanti, S., Rivera, R., Cochran, A., Tungol, J. G., Fayazmanesh, N. and Weinmann, E., PLoS ONE, 2017, 12(3), e0173869.
- Arankalle, D. V., Int. J. Prev. Med., 2013, 4(1), 120–121.
- Jabin, F., Afr. J. Trad., Complement. Altern. Med., 2011, 8(5), 140–143.
- Mutheeswaran, S., Pandikumar, P., Chellappandian, M. and Ignacimuthu, S., J. Ethnopharmacol., 2011, 137(1), 523– 533.
- Subbarayappa, B. V., Lancet, 1997, 350(9094), 1841–1844.
- Anjana, R. M., Deepa, M., Pradeepa, R., Mahanta, J., Narain, K., Das, H. K. and Yajnik, C. S., Lancet Diabetes Endocrinol., 2017, 5(8), 585–596.
- Finer, S., Robb, P., Cowan, K., Daly, A., Robertson, E. and Farmer, A., Lancet Diabetes Endocrinol., 2017, 5(12), 935– 936.
- Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T. and Vollmer, S., Lancet Diabetes Endocrinol., 2017, 5(6), 423– 430.
- Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D. and Geiss, L., N. Engl. J. Med., 2014, 371(3), 286–287.
- Dubey, N. K., Kumar, R. and Tripathi, P., Curr. Sci., 2004, 86(1), 37–41.
- Sahoo, N. and Manchikanti, P., J. Altern. Complement. Med., 2013, 19(12), 957– 963.
- Agoramoorthy, G. and Hsu, M. J., AsiaPac. J. Social Work Dev., 2013, 23(1), 59–70.